Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.
About
XCath develops next-generation endovascular robotics and steerable neurovascular guidewires designed for enhanced precision in navigating the human vasculature. Their technology aims to enable expert navigation of complex anatomy, democratize access to critical care, and improve clinical outcomes for minimally invasive treatments of vascular conditions. XCath serves the medical field by providing advanced tools for endovascular procedures.
Tags
Total Employees
31
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
63Traction
54Team
30Visibility
13Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does XCath do?
XCath develops next-generation endovascular robotics and steerable neurovascular guidewires designed for enhanced precision in navigating the human vasculature. Their technology aims to enable expert navigation of complex anatomy, democratize access to critical care, and improve clinical outcomes for minimally invasive treatments of vascular conditions. XCath serves the medical field by providing advanced tools for endovascular procedures.
How much funding has XCath raised?
XCath has raised a total of $54M in funding. The most recent round on record is Series C.
Where is XCath headquartered?
XCath is headquartered in Houston, United States.
When was XCath founded?
XCath was founded in 2017.
What industry does XCath operate in?
XCath operates in Medical Devices, Robotics, Healthcare, Biotechnology, HealthTech, Surgical Robotics.
How many employees does XCath have?
XCath has approximately 31 people on record.